Dublin, Ireland – 30 January 2025 – ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of ...
Leo Clancy, CEO, Enterprise Ireland, commented: “Enterprise Ireland is delighted to support ICON in advancing its AI capabilities, which are driving significant innovation in the clinical trial ...
While poorly collected data can introduce noise, properly collected data allows clinical trial leads to quickly consolidate and analyze this information. 2 And they often require support with this ...
ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...